Tiffany Weksberg, PhD

Patent Agent
Norton Rose Fulbright US LLP
tiffany.weksberg@nortonrosefulbright.com
Tiffany
Weksberg
Tiffany Weksberg, PhD

Tiffany Weksberg is a patent agent with extensive experience helping clients develop, protect and enforce intellectual property portfolios across a wide range of sectors, including life sciences, computer science and energy sectors. She focuses on patent procurement and portfolio management, advising clients on strategies to protect innovation and support business objectives.

Tiffany has extensive experience preparing and prosecuting US patent applications through all stages of patent examination, including invention harvesting, patent drafting, responding to office actions, examiner interviews and appeal briefing. Within life sciences, for example, Tiffany’s practice spans a broad range of technologies, including gene therapies, cell therapies, immunotherapies, antibodies, protein engineering, computational biology and bioinformatics.

Prior to joining Norton Rose Fulbright, Tiffany gained in-house intellectual property experience with an oil and gas company, where she provided strategic patent counseling and supported innovation initiatives in the energy sector. Her combination of in-house and law firm experience provides clients with a practical, business-focused perspective on intellectual property protection, helping organizations align their patent strategies with broader commercial and innovation objectives.

Representative experience

  • Gene therapy including viral delivery systems
  • Gene editing including CRISPR/Cas9, TALENs, ZFNs and miRNA technologies
  • Proteins and peptides including antibodies, single-domain antibodies, antibody-based polypeptides, receptors and ligands and CAR-T technologies
  • Polypeptide therapeutics
  • Antibody therapeutics
  • T-cell receptor and immunotherapy technologies
  • Nucleic-acid therapeutics including siRNA, mRNA and miRNA
  • Cell therapies including CAR-T, TCR-based therapies, NK cells, fibroblasts, iPS cells, stem cells and MSCs
  • Computational Biology
  • Computational protein design
  • Protein drug interaction analysis and modeling
  • Computational evaluation of protein and nucleic acid therapeutics

Awards and recognitions

  • Pre-doctoral Fellowship, W. M. Keck Center for Computational and Structural Biology of the Gulf Coast Consortia (July 2002- July 2005)

Education

  • PhD, Structural and Computational Biology and Molecular Biophysics, Baylor College of Medicine, 2008
  • BS, Biochemistry, College of Letters and Science, Univeristy of California at Santa Barbara, 2001
  • BS, cum laude, Computer Science, College of Engineering, University of California at Santa Barbara, 2001

Admissions

  • US Patent and Trademark Agent

Speaking engagements

  • "Molecular Dynamics Simulations of the Trichomonas Vaginalis Ferredoxin,"  Houston Society for Engineering in Medicine and Biology, Houston, Texas, February 2004

Publications

  • Weksberg TE, Lynch GC, Krause KL, Pettitt BM. “Molecular Dynamics Simulations of Trichomonas vaginalis Ferredoxin Show a Loop-Cap Transition.” Biophysical Journal. 2007 May 15;92(10):3337-45.
  • Chen C, Beck BW, Krause KL, Weksberg TE, Pettitt BM. “The Effects of Dimerization of Serratia marcescens Endonuclease on Water Dynamics” Biopolymers. 2007 Feb 15;85(3):241-52
  • Kong Y, Shen Y, Warth TE, Ma J. “Conformational pathways in the gating of Escherichia coli mechanosensitive channel.” PNAS. 2002 Apr 30;99(9):5999-6004.
  • Kim J, Noskov VN, Lu X, Bergmann A, Ren X, Warth T, Richardson P, Kouprina N, Stubbs L. “Discovery of a novel, paternally expressed ubiquitin-specific processing protease gene through comparative analysis of an imprinted region of mouse chromosome 7 and human chromosome 19q13.4.” Genome Research. 2000 Aug, 10(8): 1138-47.

Membership and activities

  • American Intellectual Property Law Association
  • Houston Intellectual Property Law Association
Bio